30 closest matches · ranked by relevance
Cesarean Section; Complications · Placenta Previa · Placenta Accreta
Primary: Placenta Previa — 18; 17; 0; 3 Participants
Cesarean Section Complications
Primary: Cesarean Scar Defect in the Uterine Incisional Line — 12; 39 participants — p=0.0001
Major Puerperal Infection, Postpartum · Wound Complications · Wound Seroma
Primary: Wound Complication Rate — 3; 1; 3; 6 participants
Other Chronic Postoperative Pain
Primary: Severity of Acute Pain — 46; 31 mm — p=0.05
Cesarean Section; Complications, Wound, Dehiscence
Primary: Number of Participants With Wound Disruption and/or Infection — 5; 9 Participants
Post-operative Complications · Surgical Site Infection · Surgical Wound Infection
Primary: Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. — 7; 2 participants
Wound Infections
Primary: Number of Participants With Composite Surgical Site Infection (SSI) or Other Wound Complication. — 5; 3 Participants — p=0.72
Hypertrophic Skin Condition of Anterior Abdomen
Primary: Subjective Cosmetic Result — 13; 26.5 units on a scale
Postoperative Wound Complications
Primary: Number of Participants With Wound Complication — 37; 42 Participants — p=0.54
Cesarean Section · Wound Complications · Patient Satisfaction
Primary: Number of Participants With Wound Complications — 18; 40; 9; 14 Participants
Surgery · Opioid Use
Primary: Unused Opioids — 5; 10 oxycodone 5mg tablets
Complications; Cesarean Section · Surgical Wound Infection
Primary: Number of Participants With Wound Complications (Surgical Site Infection (SSI), Hematoma, Separation, Seroma, Etc) — 23; 37; 16; 25 Participants — p=0.04
Persistent Pain After Delivery
Primary: Persistent Pain-PERCEIVED STRESS Scores Stratified by the Rate of Recovery — 11.4; 12.9; 15.4 units on a scale — p=<0.01
Cesarean Section
Primary: Opioid Consumption — 60.34; 104.33 oral morphine equivalents (mg) — p=< 0.001
Wound Complication
Primary: Number of Participants With Wound Complications — 3; 4 Participants
Uterine Scar · Cesarean Section Complications · Cesarean Section; Dehiscence
Primary: Number of Participants With Niche Visualized by Saline Infusion Sonography — 40; 53; 25; 23 Participants — p=0.05
Infection
Primary: Endometritis and Wound Infection — 6; 4 patients infected
High Risk Pregnancy · Cesarean Wound Disruption With Postnatal Complication
Primary: Wound Complication — 13; 14 Participants
Respiratory Disorders · Intensive Care, Neonatal
Primary: Neonatal Admission After Elective Caesarean Section — 88; 76 participants — p=0.31
Surgical Site Infection · Cosmetic Appearance of Cesarean Scar · Post Operative Pain
Primary: Percentage of Patients Who Develop a Surgical Site Infection — 14; 15 Participants — p=<0.05
Pregnancy · Cesarean Section
Primary: Level of Pain on a Scale During the Post-operative Hospitalization Period — 2.0; 2.0 units on a scale — p=0.60
D001458 · D011247
Primary: Infection Rate — 17; 18; 5; 5 Participants
Postpartum Disorder
Primary: Steps — 968; 1771; 1652; 3165 Steps — p=0.002
Pregnancy · Obese
Primary: Wound Infection or Disruption — 38; 37 participants
Pain, Postoperative · Anxiety · Postpartum Complication
Primary: Count of Participants Who Reported HIGH PAIN After the Intervention — 2; 7 Participants — p=.019
Pain
Primary: Post-operative Pain — 15; -31 Scores on a scale — p=0.04
Wound Complications
Primary: Composite Wound Complication — 34; 15 Participants
Cesarean Section · Pain · Anxiety
Primary: Wellbeing Measured Using a Comfort Scale — 6.7; 8.0 units on a scale
Pain, Postoperative
Primary: Total Morphine Milliequivalent (MME) Use Postoperatively After Cesarean Delivery — 52; 68 Morphine milligram equivalents
Cesarean Section
Primary: Discharge on Postoperative Day #2 — 5; 2 Participants